STUDIES OF CYCLODEXTRIN INCLUSION COMPLEXES .1. THE SALBUTAMOL-CYCLODEXTRIN COMPLEX AS STUDIED BY PHASE SOLUBILITY AND DSC

被引:157
作者
MARQUES, HMC [1 ]
HADGRAFT, J [1 ]
KELLAWAY, IW [1 ]
机构
[1] UNIV WALES COLL CARDIFF,WELSH SCH PHARM,POB 13,CARDIFF CF1 3XF,WALES
关键词
Cyclodextrin; α-; β-; Di-O-methyl-β-cyclodextrin derivative; DSC; Inclusion complexation; Salbutamol; Solubility; Stability constant;
D O I
10.1016/0378-5173(90)90132-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclodextrins (CYDs) are cyclic non-reducing oligosaccharides built up from six, seven or eight glucopyranose units (α-, β- or γ-CYD, respectively). Many drugs are able to form an inclusion complex with CYDs, being trapped entirely or at least partially into their slightly apolar cavities. Complexes of CYDs and salbutamol were obtained in both the liquid and solid state. The influence of both temperature and CYD concentration on complex solubility was studied using the method of Higuchi and Connors (Adv. Anal. Chem., 4 (1965) 117-212). This is based on monitoring changes in the solubility of substrate (salbutamol) on the addition of complexing agents (α-, β-, Me-β- and γ-CYD). The rate of increase in substrate solubility with CYD concentration varied with the type of CYD used (Me-β->β-≫γ->α-CYD). As salbutamol is water soluble and an AL type diagram is obtained, the solid complex was prepared by freeze-drying (lyophilization). In order to confirm solid complex formation, differential scanning calorimetry (DSC) was used. When guest molecules are incorporated in the CYD cavity, their melting, boiling or sublimation points usually shift to a different temperature or disappear within the temperature range where the CYD is decomposed. The thermograms obtained showed an endothermic peak for the freeze-dried salbutamol and for the physical mixture (salbutamol and β-CYD both freeze-dried) which was eliminated for the inclusion complex. © 1990.
引用
收藏
页码:259 / 266
页数:8
相关论文
共 31 条
[1]  
Andersen F.M., 1982, ARCH PHARM CHEMI SCI, V10, P80
[2]   CHARACTERIZATION, DISSOLUTION AND BIOAVAILABILITY IN RATS OF IBUPROFEN - BETA-CYCLODEXTRIN COMPLEX SYSTEM [J].
CHOW, DD ;
KARARA, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 28 (2-3) :95-101
[3]   MECHANISM OF DRUG DISSOLUTION RATE ENHANCEMENT FROM BETA-CYCLODEXTRIN-DRUG SYSTEMS [J].
CORRIGAN, OI ;
STANLEY, CT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :621-626
[4]  
DUCHENE D, 1986, CYCLODEXTRINS THEIR, P211
[5]   A STUDY OF THE INCLUSION COMPLEX OF NAPROXEN WITH BETA-CYCLODEXTRIN [J].
ERDEN, N ;
CELEBI, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :83-89
[6]  
FROMMING KH, 1987, TOP PHARM SCI, P169
[7]  
FUJIOKA K, 1983, CHEM PHARM BULL, V31, P2416
[8]  
HAMADA Y, 1975, CHEM PHARM BULL, V23, P1205
[9]   IMPROVEMENT OF THE INVITRO DISSOLUTION CHARACTERISTICS OF FAMOTIDINE BY INCLUSION IN BETA-CYCLODEXTRIN [J].
HASSAN, MA ;
SULEIMAN, MS ;
NAJIB, NM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 58 (01) :19-24
[10]  
Higuchi T., 1965, PHASE SOLUBILITY TEC, V4, P117